1. Home
  2. SHFS vs PPCB Comparison

SHFS vs PPCB Comparison

Compare SHFS & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

HOLD

Current Price

$0.88

Market Cap

2.7M

Sector

Finance

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

HOLD

Current Price

$0.11

Market Cap

3.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHFS
PPCB
Founded
2015
2007
Country
United States
Australia
Employees
41
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SHFS
PPCB
Price
$0.88
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
84.0K
1.4M
Earning Date
03-30-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.10
52 Week High
$9.18
$10.69

Technical Indicators

Market Signals
Indicator
SHFS
PPCB
Relative Strength Index (RSI) 44.37 25.73
Support Level $0.79 N/A
Resistance Level $1.03 $0.40
Average True Range (ATR) 0.10 0.01
MACD 0.01 0.00
Stochastic Oscillator 24.48 0.99

Price Performance

Historical Comparison
SHFS
PPCB

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: